TSTL Stock Overview
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally.
Price History & Performance
|Historical stock prices|
|Current Share Price||UK£3.40|
|52 Week High||UK£6.70|
|52 Week Low||UK£2.70|
|1 Month Change||6.25%|
|3 Month Change||6.25%|
|1 Year Change||-41.38%|
|3 Year Change||10.57%|
|5 Year Change||62.29%|
|Change since IPO||580.00%|
Recent News & Updates
Bearish: Analysts Just Cut Their Tristel plc (LON:TSTL) Revenue and EPS estimates
Today is shaping up negative for Tristel plc ( LON:TSTL ) shareholders, with the analysts delivering a substantial...
|TSTL||GB Medical Equipment||GB Market|
Return vs Industry: TSTL underperformed the UK Medical Equipment industry which returned -16.9% over the past year.
Return vs Market: TSTL underperformed the UK Market which returned -3% over the past year.
|TSTL Average Weekly Movement||6.6%|
|Medical Equipment Industry Average Movement||6.2%|
|Market Average Movement||6.0%|
|10% most volatile stocks in GB Market||11.6%|
|10% least volatile stocks in GB Market||3.1%|
Stable Share Price: TSTL is not significantly more volatile than the rest of UK stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: TSTL's weekly volatility (7%) has been stable over the past year.
About the Company
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand; contamination control products, which include cleanroom, laboratory, pharmaceutical, cosmetic, and toiletry disinfectants under the Crystel brand; and airborne and veterinary device disinfectants under the Anistel brand.
Tristel Fundamentals Summary
|TSTL fundamental statistics|
Is TSTL overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|TSTL income statement (TTM)|
|Cost of Revenue||UK£6.14m|
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
|Earnings per share (EPS)||0.048|
|Net Profit Margin||7.64%|
How did TSTL perform over the long term?See historical performance and comparison
1.9%Current Dividend Yield
Is Tristel undervalued compared to its fair value and its price relative to the market?
Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: TSTL (£3.4) is trading below our estimate of fair value (£4.76)
Significantly Below Fair Value: TSTL is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: TSTL is poor value based on its Price-To-Earnings Ratio (70.2x) compared to the UK Medical Equipment industry average (26.9x).
PE vs Market: TSTL is poor value based on its Price-To-Earnings Ratio (70.2x) compared to the UK market (15.3x).
Price to Earnings Growth Ratio
PEG Ratio: TSTL is poor value based on its PEG Ratio (1.7x)
Price to Book Ratio
PB vs Industry: TSTL is overvalued based on its Price-To-Book Ratio (5.8x) compared to the GB Medical Equipment industry average (2.8x).
How is Tristel forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Future Growth Score4/6
Future Growth Score 4/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TSTL's forecast earnings growth (41.4% per year) is above the savings rate (0.9%).
Earnings vs Market: TSTL's earnings (41.4% per year) are forecast to grow faster than the UK market (11.3% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: TSTL's revenue (10.6% per year) is forecast to grow faster than the UK market (4.1% per year).
High Growth Revenue: TSTL's revenue (10.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: TSTL's Return on Equity is forecast to be low in 3 years time (11.6%).
How has Tristel performed over the past 5 years?
Past Performance Score1/6
Past Performance Score 1/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: TSTL has a large one-off loss of £874.0K impacting its December 31 2021 financial results.
Growing Profit Margin: TSTL's current net profit margins (7.6%) are lower than last year (14.4%).
Past Earnings Growth Analysis
Earnings Trend: TSTL's earnings have grown by 1% per year over the past 5 years.
Accelerating Growth: TSTL's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: TSTL had negative earnings growth (-50.1%) over the past year, making it difficult to compare to the Medical Equipment industry average (22.3%).
Return on Equity
High ROE: TSTL's Return on Equity (8.2%) is considered low.
How is Tristel's financial position?
Financial Health Score6/6
Financial Health Score 6/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: TSTL's short term assets (£17.4M) exceed its short term liabilities (£3.1M).
Long Term Liabilities: TSTL's short term assets (£17.4M) exceed its long term liabilities (£6.0M).
Debt to Equity History and Analysis
Debt Level: TSTL is debt free.
Reducing Debt: TSTL has not had any debt for past 5 years.
Debt Coverage: TSTL has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: TSTL has no debt, therefore coverage of interest payments is not a concern.
What is Tristel current dividend yield, its reliability and sustainability?
Dividend Score 3/6
Future Dividend Coverage
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: TSTL's dividend (1.93%) is higher than the bottom 25% of dividend payers in the UK market (1.8%).
High Dividend: TSTL's dividend (1.93%) is low compared to the top 25% of dividend payers in the UK market (4.82%).
Stability and Growth of Payments
Stable Dividend: TSTL's dividend payments have been volatile in the past 10 years.
Growing Dividend: TSTL's dividend payments have increased over the past 10 years.
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (134.6%), TSTL's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonable cash payout ratio (68.3%), TSTL's dividend payments are covered by cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Paul Swinney (62 yo)
Mr. Paul C. Swinney serves as the Chief Executive Officer of Tristel Plc. since 1993 and serves as its Director. Mr. Swinney started his career with Brown, Shipley & Co in 1980.He worked for the European...
CEO Compensation Analysis
Compensation vs Market: Paul's total compensation ($USD2.84M) is above average for companies of similar size in the UK market ($USD679.19K).
Compensation vs Earnings: Paul's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
Experienced Board: TSTL's board of directors are considered experienced (3.4 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: TSTL insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Tristel plc's employee growth, exchange listings and data sources
- Name: Tristel plc
- Ticker: TSTL
- Exchange: AIM
- Founded: 1993
- Industry: Health Care Supplies
- Sector: Healthcare
- Implied Market Cap: UK£160.565m
- Shares outstanding: 47.22m
- Website: https://www.tristel.com
Number of Employees
- Tristel plc
- Lynx Business Park
- Unit 1B
- CB8 7NY
- United Kingdom
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/25 00:00|
|End of Day Share Price||2022/05/25 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.